Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 261

1.

Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.

Mathew B, Parambi DGT, Mathew GE, Uddin MS, Inasu ST, Kim H, Marathakam A, Unnikrishnan MK, Carradori S.

Arch Pharm (Weinheim). 2019 Sep 3:e1900177. doi: 10.1002/ardp.201900177. [Epub ahead of print] Review.

PMID:
31478569
2.

"DIABETIC TAX" - Cost of Care among Persons with Type 2 Diabetes Mellitus in an Urban Underprivileged Area of Bengaluru.

Mathew G, Fathima FN, Agrawal T, Misquith D.

Indian J Community Med. 2019 Apr-Jun;44(2):113-117. doi: 10.4103/ijcm.IJCM_224_18.

3.

Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.

Harilal S, Jose J, Parambi DGT, Kumar R, Mathew GE, Uddin MS, Kim H, Mathew B.

J Pharm Pharmacol. 2019 Sep;71(9):1370-1383. doi: 10.1111/jphp.13132. Epub 2019 Jul 15. Review.

PMID:
31304982
4.

Perspective design of chalcones for the management of CNS disorders: A mini-review.

Mathew B, Parambi DGT, Uddin MS, Suresh J, Mathew GE, Joy M, Marathakam A, Gupta SV.

CNS Neurol Disord Drug Targets. 2019 Jun 10. doi: 10.2174/1871527318666190610111246. [Epub ahead of print]

PMID:
31187716
5.

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.

Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D'Andrea VD, Lee MF, Swamynathan MM, Casanova-Salas I, Jibilian MC, Buckholtz CL, Ambrico AJ, Pan CH, Wilkinson JE, Newton AC, Trotman LC.

J Cell Biol. 2019 Jun 3;218(6):1943-1957. doi: 10.1083/jcb.201902048. Epub 2019 May 15.

PMID:
31092557
6.

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience.

Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM.

VideoGIE. 2019 Apr 29;4(5):223-225. doi: 10.1016/j.vgie.2019.02.009. eCollection 2019 May. No abstract available.

7.

Sleep duration and social jetlag are independently associated with anxious symptoms in adolescents.

Mathew GM, Li X, Hale L, Chang AM.

Chronobiol Int. 2019 Apr;36(4):461-469. doi: 10.1080/07420528.2018.1509079. Epub 2019 Feb 20.

PMID:
30786775
8.

Sex Moderates Relationships Among School Night Sleep Duration, Social Jetlag, and Depressive Symptoms in Adolescents.

Mathew GM, Hale L, Chang AM.

J Biol Rhythms. 2019 Apr;34(2):205-217. doi: 10.1177/0748730419828102. Epub 2019 Feb 18.

PMID:
30773079
9.

Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.

Mathew B, Baek SC, Thomas Parambi DG, Lee JP, Mathew GE, Jayanthi S, Vinod D, Rapheal C, Devikrishna V, Kondarath SS, Uddin MS, Kim H.

Arch Pharm (Weinheim). 2019 Apr;352(4):e1800309. doi: 10.1002/ardp.201800309. Epub 2019 Jan 21.

PMID:
30663112
10.

Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.

Mathew B, Baek SC, Grace Thomas Parambi D, Pil Lee J, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H.

Medchemcomm. 2018 Sep 25;9(11):1871-1881. doi: 10.1039/c8md00399h. eCollection 2018 Nov 1.

11.

Expression of Metallothionein after Administration of Aspirin, Vitamin C or Zinc Supplement in the DMH Induced Colon Carcinoma in Rat

Christudoss P, Chacko G, Selvakumar R, Fleming JJ, Pugazhendhi S, Mathew G.

Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3237-3244.

12.

Fe3 O4 nanoparticles mediated synthesis of novel spirooxindole-dihydropyrimidinone molecules as Hsp90 inhibitors.

Maddela S, Makula A, Galigniana MD, Parambi DGT, Federicci F, Mazaira G, Hendawy OM, Dev S, Mathew GE, Mathew B.

Arch Pharm (Weinheim). 2019 Jan;352(1):e1800174. doi: 10.1002/ardp.201800174. Epub 2018 Nov 28.

PMID:
30485473
13.

Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.

Parambi DGT, Aljoufi F, Murugaiyah V, Mathew GE, Dev S, Lakshminarayanan B, Hendawy OM, Mathew B.

Cent Nerv Syst Agents Med Chem. 2019;19(1):67-71. doi: 10.2174/1871524918666181119114016.

PMID:
30451121
14.

A novel synthetic small molecule DMFO targets Nrf2 in modulating proinflammatory/antioxidant mediators to ameliorate inflammation.

Mathew G, Sharma A, Pickering RJ, Rosado CJ, Lemarie J, Mudgal J, Thambi M, Sebastian S, Jandeleit-Dahm KA, de Haan JB, Unnikrishnan MK.

Free Radic Res. 2018 Oct;52(10):1140-1157. doi: 10.1080/10715762.2018.1533636. Epub 2018 Nov 13.

PMID:
30422019
15.

Renal Mucormycosis: A Rare Cause of Urinary Tract Infection Leading to End-stage Renal Disease (ESRD).

Mathew G, Arumugam V, Murugesan S, Duhli N, Agarwal I.

J Trop Pediatr. 2019 Aug 1;65(4):405-408. doi: 10.1093/tropej/fmy059.

PMID:
30252109
16.

Splenic Abscess.

Waheed A, Mathew G, Zemaitis MR.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jul 4.

17.

Amebiasis.

Zulfiqar H, Mathew G, Horrall S.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Sep 5.

18.

The role of sleep deprivation and fatigue in the perception of task difficulty and use of heuristics.

Engle-Friedman M, Mathew GM, Martinova A, Armstrong F, Konstantinov V.

Sleep Sci. 2018 Mar-Apr;11(2):74-84. doi: 10.5935/1984-0063.20180016.

19.

Single-cell RNA-seq analysis identifies markers of resistance to targeted BRAF inhibitors in melanoma cell populations.

Ho YJ, Anaparthy N, Molik D, Mathew G, Aicher T, Patel A, Hicks J, Hammell MG.

Genome Res. 2018 Sep;28(9):1353-1363. doi: 10.1101/gr.234062.117. Epub 2018 Jul 30.

20.

Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@erGO) nanocomposite for selective detection of Parkinson's disease biomarker.

Mathew G, Dey P, Das R, Chowdhury SD, Paul Das M, Veluswamy P, Neppolian B, Das J.

Biosens Bioelectron. 2018 Sep 15;115:53-60. doi: 10.1016/j.bios.2018.05.024. Epub 2018 May 22.

PMID:
29800831

Supplemental Content

Loading ...
Support Center